11-119026079-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000330775.9(SLC37A4):āc.872C>Gā(p.Ala291Gly) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000107 in 1,586,762 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/13 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A291V) has been classified as Likely benign.
Frequency
Consequence
ENST00000330775.9 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC37A4 | NM_001164277.2 | c.872C>G | p.Ala291Gly | missense_variant, splice_region_variant | 9/11 | ENST00000642844.3 | |
SLC37A4 | NM_001164279.2 | c.653C>G | p.Ala218Gly | missense_variant, splice_region_variant | 9/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC37A4 | ENST00000330775.9 | c.872C>G | p.Ala291Gly | missense_variant, splice_region_variant | 8/10 | 5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000546 AC: 83AN: 152136Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000192 AC: 40AN: 208402Hom.: 0 AF XY: 0.000197 AC XY: 22AN XY: 111666
GnomAD4 exome AF: 0.0000606 AC: 87AN: 1434508Hom.: 0 Cov.: 30 AF XY: 0.0000562 AC XY: 40AN XY: 711284
GnomAD4 genome AF: 0.000545 AC: 83AN: 152254Hom.: 0 Cov.: 32 AF XY: 0.000672 AC XY: 50AN XY: 74436
ClinVar
Submissions by phenotype
Glucose-6-phosphate transport defect Uncertain:2
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Nov 17, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Aug 31, 2022 | This sequence change replaces alanine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 291 of the SLC37A4 protein (p.Ala291Gly). This variant is present in population databases (rs200147602, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with SLC37A4-related conditions. ClinVar contains an entry for this variant (Variation ID: 969047). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 07, 2022 | The p.A291G variant (also known as c.872C>G), located in coding exon 6 of the SLC37A4 gene, results from a C to G substitution at nucleotide position 872. The alanine at codon 291 is replaced by glycine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 31, 2023 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at